Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
  • A61P1/10—Laxatives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/04—Centrally acting analgesics, e.g. opioids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
  • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
  • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
  • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
  • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
  • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
  • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Engineering & Computer Science (AREA)
• Public Health (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Biomedical Technology (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Pain & Pain Management (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Plural Heterocyclic Compounds (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Applications Claiming Priority (2)

Publications (2)

Family

ID=29406753

Family Applications (2)

Family Applications Before (1)

Country Status (23)

Families Citing this family (15)

Family Cites Families (13)

• 2003
  • 2003-03-26 US US10/400,006 patent/US7041681B2/en not_active Expired - Lifetime
  • 2003-04-17 JP JP2004500872A patent/JP4969039B2/ja not_active Expired - Fee Related
  • 2003-04-17 PL PL396160A patent/PL219912B1/pl unknown
  • 2003-04-17 CN CN2008100865985A patent/CN101255131B/zh not_active Expired - Lifetime
  • 2003-04-17 DK DK03719805.8T patent/DK1499313T3/da active
  • 2003-04-17 AU AU2003223664A patent/AU2003223664A1/en not_active Abandoned
  • 2003-04-17 ES ES03719805T patent/ES2366471T3/es not_active Expired - Lifetime
  • 2003-04-17 AT AT03719805T patent/ATE514425T1/de active
  • 2003-04-17 CN CN038151995A patent/CN1665501B/zh not_active Expired - Lifetime
  • 2003-04-17 HR HRP20130893AA patent/HRP20130893A2/hr not_active Application Discontinuation
  • 2003-04-17 HR HRP20041014AA patent/HRP20041014B1/hr not_active IP Right Cessation
  • 2003-04-17 PL PL374053A patent/PL211163B1/pl unknown
  • 2003-04-17 CA CA2753371A patent/CA2753371C/en not_active Expired - Lifetime
  • 2003-04-17 CA CA2483662A patent/CA2483662C/en not_active Expired - Lifetime
  • 2003-04-17 KR KR1020047017395A patent/KR101287409B1/ko not_active Expired - Lifetime
  • 2003-04-17 ES ES10180687.5T patent/ES2608840T3/es not_active Expired - Lifetime
  • 2003-04-17 PT PT03719805T patent/PT1499313E/pt unknown
  • 2003-04-17 WO PCT/US2003/011872 patent/WO2003092688A2/en not_active Ceased
  • 2003-04-17 SI SI200332038T patent/SI1499313T1/sl unknown
  • 2003-04-17 BR BRPI0309708A patent/BRPI0309708B1/pt not_active IP Right Cessation
  • 2003-04-17 NZ NZ561795A patent/NZ561795A/en not_active IP Right Cessation
  • 2003-04-17 EP EP03719805A patent/EP1499313B1/en not_active Expired - Lifetime
  • 2003-04-17 KR KR1020137005624A patent/KR101377078B1/ko not_active Expired - Fee Related
  • 2003-04-17 CA CA2883629A patent/CA2883629A1/en not_active Abandoned
  • 2003-04-17 NZ NZ575640A patent/NZ575640A/en not_active IP Right Cessation
  • 2003-04-17 MX MXPA04011947A patent/MXPA04011947A/es active IP Right Grant
  • 2003-04-17 HU HUE10180687A patent/HUE031331T2/hu unknown
  • 2003-04-17 EP EP10180687.5A patent/EP2275105B1/en not_active Expired - Lifetime
  • 2003-04-17 RU RU2004131829/04A patent/RU2332411C2/ru active
• 2004
  • 2004-10-28 IL IL164910A patent/IL164910A/en active IP Right Grant
  • 2004-11-25 NO NO20045159A patent/NO332722B1/no not_active IP Right Cessation
• 2005
  • 2005-03-14 US US11/079,573 patent/US7202381B2/en not_active Expired - Lifetime
  • 2005-10-04 US US11/242,763 patent/US7659402B2/en not_active Expired - Lifetime
• 2009
  • 2009-03-17 IL IL197642A patent/IL197642A/en active IP Right Grant
  • 2009-11-05 AU AU2009233679A patent/AU2009233679B2/en not_active Expired
• 2011
  • 2011-05-20 AU AU2011202364A patent/AU2011202364B2/en not_active Expired
  • 2011-09-22 CY CY20111100920T patent/CY1111858T1/el unknown
• 2012
  • 2012-07-09 NO NO20120788A patent/NO335607B1/no not_active IP Right Cessation
• 2014
  • 2014-04-24 NO NO20140530A patent/NO20140530L/no unknown

Also Published As

Similar Documents

Legal Events